84.22
0.50%
-0.42
Schlusskurs vom Vortag:
$84.64
Offen:
$83.49
24-Stunden-Volumen:
991.35K
Relative Volume:
2.13
Marktkapitalisierung:
$5.98B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-224.29M
KGV:
-45.52
EPS:
-1.85
Netto-Cashflow:
$-153.27M
1W Leistung:
-3.04%
1M Leistung:
-7.62%
6M Leistung:
+7.42%
1J Leistung:
+16.87%
Nuvalent Inc Stock (NUVL) Company Profile
Firmenname
Nuvalent Inc
Sektor
Branche
Telefon
508-446-2272
Adresse
ONE BROADWAY, 14TH FLOOR, CAMBRIDGE
Vergleichen Sie NUVL mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
NUVL
Nuvalent Inc
|
84.22 | 5.98B | 0 | -224.29M | -153.27M | -3.47 |
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Nuvalent Inc Stock (NUVL) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-10-24 | Eingeleitet | UBS | Neutral |
2024-08-29 | Eingeleitet | Barclays | Overweight |
2024-04-17 | Eingeleitet | Jefferies | Buy |
2024-04-01 | Hochstufung | Leerink Partners | Market Perform → Outperform |
2024-02-28 | Fortgesetzt | Guggenheim | Buy |
2024-02-23 | Eingeleitet | Robert W. Baird | Outperform |
2023-09-27 | Eingeleitet | Stifel | Buy |
2023-08-08 | Eingeleitet | SVB Securities | Market Perform |
2023-07-24 | Eingeleitet | Guggenheim | Buy |
2023-01-18 | Eingeleitet | Wedbush | Outperform |
2022-06-24 | Eingeleitet | BMO Capital Markets | Outperform |
Alle ansehen
Nuvalent Inc Aktie (NUVL) Neueste Nachrichten
Franklin Resources Inc. Has $16.49 Million Stock Position in Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
Geode Capital Management LLC Acquires 73,429 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
Nuvalent to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Lelezard
Barclays PLC Has $6.97 Million Stake in Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
Pharma Trial Consultant To Pay SEC $3M Over Insider Trading - Law360
Nuvalent, Inc. (NASDAQ:NUVL) CEO Sells $2,338,470.00 in Stock - MarketBeat
Nuvalent CEO Porter James Richard sells $2.34 million in stock By Investing.com - Investing.com Canada
Nuvalent CEO Porter James Richard sells $2.34 million in stock - Investing.com India
Nuvalent's SWOT analysis: precision oncology stock poised for growth By Investing.com - Investing.com Canada
Nuvalent's SWOT analysis: precision oncology stock poised for growth - Investing.com
Lord Abbett & CO. LLC Raises Holdings in Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
(NUVL) Investment Report - Stock Traders Daily
7,417 Shares in Nuvalent, Inc. (NASDAQ:NUVL) Purchased by Virtu Financial LLC - MarketBeat
State Street Corp Sells 82,941 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
Nuvalent director Andrew Hack sells $110 million in stock By Investing.com - Investing.com Australia
Nuvalent director Andrew Hack sells $110 million in stock - Investing.com India
Nuvalent Announces Closing of Upsized Public Offering of Common Stock - The Eastern Progress Online
12,264 Shares in Nuvalent, Inc. (NASDAQ:NUVL) Purchased by Y Intercept Hong Kong Ltd - MarketBeat
Nuvalent to Participate in the Piper Sandler 36th Annual Healthcare Conference - The Eastern Progress Online
Nuvalent to Present at the 42nd Annual J.P. Morgan Healthcare Co - GuruFocus.com
Nuvalent Announces Pricing of Upsized Public Offering of Common Stock - The Eastern Progress Online
Nuvalent, Inc. (NASDAQ:NUVL) Shares Purchased by Wellington Management Group LLP - MarketBeat
Nuvalent appoints new independent director - Investing.com India
Nuvalent appoints new independent director By Investing.com - Investing.com Canada
Nuvalent Elects Grant Bogle as Independent Director - TipRanks
Nuvalent : RESTRICTED STOCK UNIT AWARD AGREEMENT FOR COMPANY EMPLOYEES UNDER THE NUVALENT, INC. 2021 STOCK OPTION AND INCENTIVE PLAN Form 8 K - Marketscreener.com
Nuvalent Appoints Grant Bogle to Board of Directors - PR Newswire
Two Sigma Advisers LP Sells 9,000 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
Verition Fund Management LLC Invests $1.07 Million in Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Trims Holdings in Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
Nuvalent Announces Public Offering of Common Stock - The Eastern Progress Online
Nuvalent: Steps Toward That Favorable Entry Point - Seeking Alpha
Edgestream Partners L.P. Has $289,000 Holdings in Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
Nuvalent, Inc. (NASDAQ:NUVL) Shares Bought by The Manufacturers Life Insurance Company - MarketBeat
Nuvalent's SWOT analysis: promising pipeline drives stock outlook By Investing.com - Investing.com UK
(NUVL) Trading Signals - Stock Traders Daily
RA Capital Management L.P. Increases Stake in Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
Nuvalent CFO Alexandra Balcom sells $957,940 in stock By Investing.com - Investing.com Australia
Parkman Healthcare Partners LLC Has $2.39 Million Stock Holdings in Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
Erste Asset Management GmbH Invests $1.14 Million in Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
Walleye Capital LLC Buys New Position in Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
Charles Schwab Investment Management Inc. Acquires 50,536 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
Nuvalent CFO Alexandra Balcom sells $957,940 in stock - Investing.com India
Fred Alger Management LLC Boosts Stake in Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
Nuvalent, Inc. (NASDAQ:NUVL) Shares Bought by Citigroup Inc. - MarketBeat
Intech Investment Management LLC Takes Position in Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
Finanzdaten der Nuvalent Inc-Aktie (NUVL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Nuvalent Inc-Aktie (NUVL) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Balcom Alexandra | Chief Financial Officer |
Dec 17 '24 |
Option Exercise |
4.88 |
13,700 |
66,923 |
47,000 |
Pelish Henry E. | Chief Scientific Officer |
Dec 16 '24 |
Option Exercise |
0.75 |
10,414 |
7,759 |
43,714 |
Porter James Richard | President and CEO |
Dec 16 '24 |
Option Exercise |
27.85 |
27,000 |
751,950 |
215,113 |
Porter James Richard | President and CEO |
Dec 16 '24 |
Sale |
86.61 |
27,000 |
2,338,436 |
188,113 |
Hack Andrew A. F. | Director |
Dec 11 '24 |
Sale |
88.00 |
1,250,000 |
110,000,000 |
1,447,267 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):